Polifarma completed the acquisition of Hennig Arzneimitte.

Polifarma, an Italian pharmaceutical company, completed the acquisition of Hennig Arzneimittel, a company specializing in the manufacturing and marketing of pharmaceutical products. Financial terms were not disclosed. “This investment confirms our commitment to building a future for the next generations – says Luisa Angelini, President of the Final Group. “This is a historic moment for Polifarma, now positioned within a new international dimension, anticipating a profound transformation that will reshape the company’s entire structure. Hennig’s entrepreneurial journey is a remarkable story of adaptability and international expansion, one that allows us to strengthen our global positioning and pave the way for growth and innovation by enhancing specific competencies," Luisa Angelini, Final Group President.